Cryo-Cell International Inc
CCEL4.990USD
+0.030+0.60%
Horário de mercado （ET）Cotações atrasadas em 15 min
40.24MValor de mercado
312.64P/L TTM
Mais detalhes de Cryo-Cell International Inc Empresa
Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 235,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
Informações da empresa
Código da empresaCCEL
Nome da EmpresaCryo-Cell International Inc
Data de listagemApr 04, 1994
CEOMr. Mark L. Portnoy
Número de funcionários82
Tipo de títulosOrdinary Share
Fim do ano fiscalApr 04
Endereço700 Brooker Creek Blvd
CidadeOLDSMAR
Bolsa de valoresNYSE American Consolidated
PaísUnited States of America
Código postal34677
Telefone18137492104
Sitehttps://www.cryo-cell.com/
Código da empresaCCEL
Data de listagemApr 04, 1994
CEOMr. Mark L. Portnoy
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David I. Portnoy
Mr. David I. Portnoy
Chairman of the Board, Co-Chief Executive Officer
Chairman of the Board, Co-Chief Executive Officer
1.57M
--
Mr. Oleg Mikulinsky
Mr. Oleg Mikulinsky
Chief Information Officer
Chief Information Officer
104.35K
--
Mr. Harold D. Berger, CPA
Mr. Harold D. Berger, CPA
Independent Director
Independent Director
57.90K
+14.88%
Ms. Jill M. Taymans
Ms. Jill M. Taymans
Chief Financial Officer, Vice President - Finance
Chief Financial Officer, Vice President - Finance
45.40K
--
Mr. Daniel Mizrahi
Mr. Daniel Mizrahi
Independent Director
Independent Director
30.63K
--
Dr. Joanne Kurtzberg, M.D.
Dr. Joanne Kurtzberg, M.D.
Medical Director
Medical Director
--
--
Ms. Irene Smith
Ms. Irene Smith
Executive Assistant / Office Manager
Executive Assistant / Office Manager
--
--
Mr. Mark L. Portnoy
Mr. Mark L. Portnoy
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David I. Portnoy
Mr. David I. Portnoy
Chairman of the Board, Co-Chief Executive Officer
Chairman of the Board, Co-Chief Executive Officer
1.57M
--
Mr. Oleg Mikulinsky
Mr. Oleg Mikulinsky
Chief Information Officer
Chief Information Officer
104.35K
--
Mr. Harold D. Berger, CPA
Mr. Harold D. Berger, CPA
Independent Director
Independent Director
57.90K
+14.88%
Ms. Jill M. Taymans
Ms. Jill M. Taymans
Chief Financial Officer, Vice President - Finance
Chief Financial Officer, Vice President - Finance
45.40K
--
Mr. Daniel Mizrahi
Mr. Daniel Mizrahi
Independent Director
Independent Director
30.63K
--
Dr. Joanne Kurtzberg, M.D.
Dr. Joanne Kurtzberg, M.D.
Medical Director
Medical Director
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Processing and storage fees
7.87M
98.71%
Public banking revenue
82.08K
1.03%
Product revenue
20.91K
0.26%
Sem dados
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Processing and storage fees
7.87M
98.71%
Public banking revenue
82.08K
1.03%
Product revenue
20.91K
0.26%
Distribuição de ações
Atualizado em: sáb, 17 de mai
Atualizado em: sáb, 17 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Portnoy (David I)
19.50%
Portnoy (Mark)
11.61%
Fleishman (Adam)
6.32%
Hamilton Lane Advisors, LLC
5.09%
SFI Advisors LLC
2.05%
Other
55.43%
Investidores
Investidores
Proporção
Portnoy (David I)
19.50%
Portnoy (Mark)
11.61%
Fleishman (Adam)
6.32%
Hamilton Lane Advisors, LLC
5.09%
SFI Advisors LLC
2.05%
Other
55.43%
Tipos de investidores
Investidores
Proporção
Individual Investor
40.39%
Investment Advisor
6.26%
Private Equity
5.09%
Hedge Fund
0.80%
Investment Advisor/Hedge Fund
0.64%
Other
46.83%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
38
4.28M
53.09%
-1.50K
2025Q1
39
4.88M
60.37%
-1.40K
2024Q4
36
4.88M
60.35%
-45.33K
2024Q3
31
4.73M
58.53%
-190.45K
2024Q2
32
4.72M
57.24%
-175.49K
2024Q1
34
4.70M
56.72%
-231.88K
2023Q4
36
4.69M
56.61%
-257.13K
2023Q3
34
4.69M
56.58%
-265.51K
2023Q2
34
4.80M
57.00%
-223.23K
2023Q1
36
5.70M
67.38%
-813.20K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Portnoy (David I)
1.57M
19.44%
--
--
Feb 28, 2025
Portnoy (Mark)
935.77K
11.58%
--
--
Feb 28, 2025
Fleishman (Adam)
509.00K
6.3%
--
--
Feb 28, 2025
Hamilton Lane Advisors, LLC
409.73K
5.07%
--
--
Jun 30, 2025
SFI Advisors LLC
165.30K
2.05%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
118.23K
1.46%
+1.28K
+1.09%
Mar 31, 2025
The MassMutual Trust Company, FSB
111.03K
1.37%
--
--
Mar 31, 2025
Mikulinsky (Oleg)
104.35K
1.29%
--
--
Feb 28, 2025
Berger (Harold D)
50.40K
0.62%
--
--
Feb 28, 2025
Topline Capital Management, LLC
47.79K
0.59%
--
--
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
iShares Micro-Cap ETF
0.01%
iShares Micro-Cap ETF
Proporção0.01%
Dividendo
Um total de
9.69M
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Jan 29, 2025
CCEL.NB Interim Cash Dividend of gross USD 0.25 paid on Feb 28, 2025 going ex on Feb 14, 2025
Feb 14, 2025
Feb 28, 2025
Feb 14, 2025
Oct 31, 2024
CCEL.NB Interim Cash Dividend of gross USD 0.25 paid on Nov 29, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Nov 29, 2024
Nov 15, 2024
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
